Výsledky vyhledávání - "Anke Stuurman"

The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative

Autor: Javier Díez-Domingo, Laurence Torcel-Pagnon, Antonio Carmona, Odile Launay, Gaël Dos Santos, Caterina Rizzo, Mendel Haag, Anke Stuurman, Jos Nauta, Alfredo Vannacci, Simon de Lusignan, Elena Del Rey, Miriam Levi, Bruno Lina, Stefania Bellino, Samantha Nye, Pieter Neels, Hanna Nohynek, Cédric Mahé

Publikováno v: Expert Review of Vaccines
Expert Review of Vaccines, 2022, 21 (12), pp.1701-1710. ⟨10.1080/14760584.2022.2137144⟩

International audience; Introduction: Fighting pandemics requires an established infrastructure for pandemic preparedness, with existing, sustainable platforms ready to be activated. This includes platforms for disease surveillance, virus circulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6088f0081ce6e036992743c48fbceb

Zobrazit plný text záznamu

Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19

Autor: Margarita Riera Montes, Ornella Punzo, Topi Turunen, Cristina Andrés Vergés, Andrés Antón Pagarolas, Anke Stuurman, Monika Redlberger-Fritz, Javier Diez-Domingo, Raija Auvinen, Caterina Rizzo, José Ángel Rodrigo Pendás, Maria Chironna

Publikováno v: Vaccine

The DRIVE project aims to establish a sustainable network to estimate brand-specific influenza vaccine effectiveness (IVE) annually. DRIVE is a public-private partnership launched in response to EMA guidance that requires effectiveness evaluation fro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede5600c268a2e878ecb1e85b17f086b

Zobrazit plný text záznamu

Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform

Autor: Margarita Riera Montes, Daniela Loconsole, GUILLERMO MENA PINILLA, Alejandro Martin-Quiros, Alexandre Descamps, Anke Stuurman, Javier Diez-Domingo, Raija Auvinen, Oana Sandulescu, Caterina Rizzo, Maria Chironna, Antonio Carmona Serrano

Publikováno v: Vaccine

DRIVE (Development of Robust and Innovative Vaccine Effectiveness) is an IMI funded public-private platform that aims to annually estimate brand-specific influenza vaccine effectiveness (IVE), for public health and regulatory purposes. IVE analyses a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efaa464845a7342e4a0d71a5e8e21be4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání